Abstract
Expansion of haemopoietic stem cells from placental blood has been obtained with a combination of flt3 ligand (FL), thrombopoietin (TPO), kit-ligand (KL) with or without interleukin-6 (IL6) in serum-replete medium. For clinical use, cell expansion in the absence of serum is a clear advantage. Therefore, stem cell expansion in serum-free (SF) medium with a combination of three (FL, TPO, KL) or four (FL, TPO, KL, IL6) growth factors was compared with the results obtained using fetal calf serum (FCS) or human serum (HS). Human CD34+ placental blood cells were cultured in the presence of FL, TPO, KL ± IL6 with SF medium, HS and FCS for up to 8 weeks. CD34+, CFC, LTC-IC content was measured at intervals. To determine the in vivo repopulating capacity of expanded cells, CD34+ expanded cells were transplanted in sublethally irradiated NOD/SCID mice. With the three growth factor combination the CD34+ cell number increased steadily up to the 8 weeks of culture. CD34+ cells were expanded 67.5-fold with SF, 11.7 with HS and 49.2 with FCS. However, when CFCs and LTC-ICs were considered, a continuous expansion was observed only with HS and FCS, whereas in SF medium after 6 weeks their number started to decline. The addition of IL-6 did not change the expansion significantly. Cells grown ex vivo for 14 days were transplanted into NOD/SCID mice. The engraftment of human cells in mice was higher for serum-replete than for SF expanded cells. Nevertheless, SF cultured cells were also able to engraft both marrow and spleen in all animals. In addition, engrafted human cells still maintained clonogenic ability. With KL, FL, TPO ± IL6 it is possible to expand haemopoietic progenitor cells in a SF medium. Compared with serum-replete cultures, the absolute number of clonogenic cells and in vivo repopulating cells is lower. Although the degree of expansion remains significant, a clinical trial still needs to be carried out to address the question of whether this expansion might be useful in reducing post-transplant aplasia.
Bone Marrow Transplantation (2002) 29, 443–448. doi:10.1038/sj.bmt.1703390
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical blood as a potential source of transplantable haemopoietic stem/progenitor cells Proc Natl Acad Sci USA 1989 86: 3828 3832
Wagner J, Kurtzberg J . Banking and transplantation of unrelated donor umbilical cord blood: status of the National Heart, Lung and Blood Institute sponsored trial Transfusion 1998 38: 807 809
Wagner JE, Broxmeyer HE, Byrd RL et al. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment Blood 1992 79: 1874 1881
Rubinstein P, Carrier C, Scaradavou A et al. Outcome among 562 recipients of placental blood transplants from unrelated donors New Engl J Med 1998 339: 1565 1577
Brenner MK . Gene transfer to hematopoietic cells New Engl J Med 1996 335: 337 339
Zandstra PW, Connelly E, Piret JM, Eaves CJ . Ontogeny related changes in the cytokine responses of primitive human haemopoietic cells Br J Haematol 1998 101: 770 778
Conneally E, Cashman J, Petzer A, Eaves CJ . Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice Proc Natl Acad Sci USA 1997 94: 9836 9841
Petzer AL, Zandstra PW, Piret JM, Eaves CJ . Different cytokines effect on primitive (CD34+CD38−) human haemopoietic cells. Novel responses to FLT3-ligand and thrombopoietin J Exp Med 1996 183: 2551 2558
Piacibello W, Sanavio F, Garetto L et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood Blood 1997 89: 2644 2653
Piacibello W, Sanavio F, Severino A et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34+ cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells Blood 1999 93: 3736 3749
Bathia M, Bonnet D, Kapp U et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex-vivo culture J Exp Med 1997 186: 619 624
Ueda T, Tsuji K, Yoshino H et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor J Clin Invest 2000 105: 1013 1021
Bruno S, Gammaitoni L, Gunetti M et al. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model J Biol Regul Homeost Agents 2001 15: 38 48
Moore MAS . Umbilical cord blood: an expandable resource J Clin Invest 2000 105: 855 856
Mobest D, Goan SR, Junghahn I et al. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells Stem Cells 1999 17: 152 161
Donaldson C, Denning-Kendall P, Bradley B, Hows J . The CD34+CD38− population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete condition: dissociation of phenotype and function Bone Marrow Transplant 2001 27: 365 371
Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering J Hematother 1996 5: 213 226
Hudak S, Thompson-Snipes L, Rocco C et al. Anti-IL-6 antibodies suppress myeloid cell production and the generation of CFU-C in long-term bone marrow cultures Exp Hematol 1992 20: 412 417
Tajima S, Tsuji K, Ebihara Y et al. Analysis of interleukin 6 receptor and gp130 expression and proliferative capability of human CD34+ cells J Exp Med 1996 184: 1357 1364
Gan OI, Murdock B, Larochelle A, Dick JE . Differential maintenance of primitive human SCID repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human marrow stromal cells Blood 1997 90: 641 650
Piacibello W, Sanavio F, Garetto L et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation Leukemia 1998 12: 718 729
Acknowledgements
We are grateful to Andrew M Garvey BAHons LTCL (TESOL) for editorial assistance. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano), from the Ministero dell'Università e della Ricerca Scientifica e Tecnologica (MURST, Roma) to WP, EM, MA and from the Associazione Donatrici Italiane di Sangue di Cordone Ombelicale (ADISCO, Sezione Piemonte).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berger, M., Fagioli, F., Piacibello, W. et al. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study. Bone Marrow Transplant 29, 443–448 (2002). https://doi.org/10.1038/sj.bmt.1703390
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703390
